This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
identifier | question |
---|---|
cord-267046-ewnjgps5 | Virus Evolution: How Does an Enveloped Virus Make a Regular Structure? |
cord-256156-mywhe6w9 | How good is automated protein docking? |
cord-256156-mywhe6w9 | True Receptors or Adaptation Bias? |
cord-255856-0xqllbzz | ( Bleil and Wassarman, 1980a; f? |
cord-284609-1q75zw6b | Is the process limited to picornaviruses? |
cord-284609-1q75zw6b | What purpose does RNA recombination serve? |
cord-266480-u8o4eitu | Three family members charged in shooting death of security guard who told a customer to put on a face mask Should schools reopen? |
cord-266480-u8o4eitu | Why do some COVID-19 patients infect many others, whereas most do n't spread the virus at all? |
cord-253259-hmn7mg8j | One pending question is, at what stage does VP4 assembly take place, before or after the assembly of VP7? |
cord-253259-hmn7mg8j | One pertinent question is, to what advantage is this asymmetry? |
cord-305173-95o5z685 | Finally, does dysregulation of cutaneous blood flow have any effect on body temperature homeostasis? |
cord-263468-996kl9jz | A Biased RNA Polymerase? |
cord-263468-996kl9jz | Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA? |
cord-263468-996kl9jz | To test this hypothesis, we sequenced the complete N gene and one third to one half of the f? |
cord-279463-bli8hwda | How can we possibly explain how the deletion of the cytoplasmic, hydrophilic segment from IyCAT reveals a cleavable signal sequence in a formerly membranespanning region? |
cord-259681-k9cnikqk | HSVI proteins were labeled for 10 min with? |
cord-259681-k9cnikqk | In parallel, monolayers were labeled for 10 min with? |
cord-318276-so5jooj0 | Borst, l?( 1986). |
cord-318276-so5jooj0 | How do eucaryotic ribosomes select initiation regions in messenger RNA? |
cord-307021-uppekume | ( C)[ 35S]proOmpA was renatured by dilution into translocation mixtures( without membranes) that contained the indicated amounts of purified trigger factor or o- aminopentyl agarose- isolated SRI? |
cord-307021-uppekume | A close analogy can be drawn between trigger factor and the SRI? |
cord-272520-7mci4mip | What mechanisms cause the foamy viruses to bud at intracellular membranes, a site of maturation that is unusual among infectious retroviruses? |
cord-271032-imc6woht | COVID-19: a double- edged sword? |
cord-271032-imc6woht | Fighting on the Front 1761 Lines or Fanning the Flames of COVID-19? |
cord-271032-imc6woht | Should we stimulate or suppress immune responses in COVID-19? 1663 Cytokine and anti- cytokine interventions Gene List to a Gene Regulatory Network Using Large Motif and Track Collections Heterogeneity among septic shock patients in a 1670 set of immunoregulatory markers Human suppressive neutrophils |
cord-291790-z5rwznmv | Which Genetic 594 Mutations Are Antigenically Important? |
cord-291790-z5rwznmv | Why are RNA virus mutation rates so damn high? |
cord-327349-rxb6zfoc | Is checkpoint blockade a friend or foe in the context of COVID-19? |
cord-252433-0e9lonq4 | But how do viruses use noncoding RNAs to promote their replication? |
cord-252433-0e9lonq4 | So which factors are required for the export of cellular mRNAs? |
cord-252433-0e9lonq4 | So, why is this uncapped viral mRNA translated more efficiently than capped cellular mRNAs? |
cord-252433-0e9lonq4 | mRNAs reach the cytoplasm? |
cord-270082-byxd4o4m | Kinetochore Aid the Understanding of Kinetochore Function in More Complex Eukaryotes? |
cord-305290-xnjwv0d7 | Belcourt, M. F., and Farabaugh, I? J.( 1990). |
cord-305290-xnjwv0d7 | Chang, L.-J., Pryciak, t?, Ganem, D.. and Varmus, H. E.( 1989. |
cord-339093-mwxkvwaz | Engineered Autonomous Human Variable Domains Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents? |
cord-312115-foy3dsq4 | CD8+ T cells with a naive- like profile upon yellow fever vaccination Targets of T Cell Responses to SARS- CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals Clinical Characteristics of Coronavirus Disease 2019 in China Has Sweden's controversial covid-19 strategy been successful? |
cord-312115-foy3dsq4 | The key to harmonization in serological SARS- CoV-2 assays? |
cord-312115-foy3dsq4 | Will antibody tests for the coronavirus really change everything? |
cord-321308-rwxhdg8r | Did SARS- CoV-2 evolve to become better adapted to humans? |
cord-321308-rwxhdg8r | More deadly? |
cord-321308-rwxhdg8r | More infectious or transmissible? |
cord-328289-3h3kmjlz | Can Covid Damage the Brain? |
cord-328289-3h3kmjlz | Does the brain contribute to respiratory failure and hypertension? |
cord-328289-3h3kmjlz | Does the brain contribute to the immune dysregulation? |
cord-328289-3h3kmjlz | Here are some of the outstanding questions: Do the neurological manifestations of COVID-19 reflect brain invasion? |
cord-328289-3h3kmjlz | What are the long- term neurological and neuropsychiatric consequences of COVID-19? |
cord-321868-xk4yuibj | Gene 46, 145- 152.Donahue, T. F., Farabaugh, f? J., and Fink, G. R.( 1982). |
cord-321868-xk4yuibj | How is this level of"inaccuracy"achieved? |
cord-321868-xk4yuibj | If the AGG codon of the frameshift site induces a translational pause as a result of the low availability of its cognate tRNA, is it possible to induce a translational pause by substituting a codon recognized by other low- abundance tRNAs? |
cord-321868-xk4yuibj | Is frameshifting constrained to occur in only one direction, or can it occur in either direction? |
cord-321868-xk4yuibj | Nature 288, 60- 63.Gafner, J., De Robertis, E. M., and Philippsen, f? |
cord-321868-xk4yuibj | Ty element transposition: reverse transcriptase and virus- like particles, Cell 42, 507- 517.Guarente, L., Yocum, R., and Gifford, t?( 1982). |
cord-321868-xk4yuibj | We thank i? |
cord-321868-xk4yuibj | Will frameshifting occur only when the TYA reading frame is being translated by the ribosome? |
cord-287815-alv30uk5 | Anyway? |
cord-287815-alv30uk5 | Are There? |
cord-287815-alv30uk5 | Are compartment boundaries defined by specific protein frameworks? |
cord-287815-alv30uk5 | Does Transport through the Golgi Require Vesicular Carriers? |
cord-287815-alv30uk5 | Does transport between Golgi compartments require vesicular carriers? |
cord-287815-alv30uk5 | How Good Is the Evidence for the Current View of the Golgi? |
cord-287815-alv30uk5 | How do microtubules interact with the Golgi elements? |
cord-287815-alv30uk5 | How does lipid composition and organization affect transport? |
cord-287815-alv30uk5 | How does the machinery responsible for forward traffic relate to the machinery controlling homotypic fusion? |
cord-287815-alv30uk5 | How is specificity of forward and backward traffic regulated? |
cord-287815-alv30uk5 | How many Golgi compartments are there? |
cord-287815-alv30uk5 | If so, how do they function and how are they regulated? |
cord-287815-alv30uk5 | If the medial Golgi serves only to mediate glycosylation reactions, why the characteristic cisternal morphology? |
cord-287815-alv30uk5 | If vesicles are not involved, is transfer from donor to acceptor Golgi mediated by direct fusion, perhaps via tubular extensions? |
cord-287815-alv30uk5 | In vitro veritas? |
cord-287815-alv30uk5 | Is Transport through the Golgi Selective or Nonselective? |
cord-287815-alv30uk5 | Is transport in vitro ever completely dependent on vesicle formation, even in the absence of BFA? |
cord-287815-alv30uk5 | The fact that"transport"( i.e., G protein glycosylation) can occur in the absence of vesicle formation raises a number of important questions: What transport step(s) is actually being measured in vitro? |
cord-287815-alv30uk5 | Vesicular Transport or Golgi Fusion? |
cord-287815-alv30uk5 | What function does the stack structure have? |
cord-287815-alv30uk5 | What is the relationship of the events reconstituted in vitro to those found in intact cells? |
cord-287815-alv30uk5 | What is the role of tubules? |
cord-287815-alv30uk5 | While transport vesicles may represent the most likely mechanism to accomplish transfer between compartments and/or individual cisternae, how strong is the evidence that they actually perform this function? |
cord-269023-g21a9ik2 | A dwindling, dispensable, involuting organ; how could it possibly be essential for human ll lives? |
cord-269023-g21a9ik2 | And could such re- infected individuals carry enough virus to infect the immunologically naive population? |
cord-269023-g21a9ik2 | And second: is it infected with a virus or a bacterium? |
cord-269023-g21a9ik2 | And so this essay looks back at history- of virology, vaccinations, and immunology- and asks: what have we learned, and what must be revisited? |
cord-269023-g21a9ik2 | And what about T cells? |
cord-269023-g21a9ik2 | Are there host factors that predict severe disease? |
cord-269023-g21a9ik2 | But how did inoculation generate immunity, particularly longterm immunity? |
cord-269023-g21a9ik2 | But how does a CD8 cell find a self- cell with a virus embedded within it? |
cord-269023-g21a9ik2 | But if B cells generate antibodies to kill microbes, what do T cells do( Miller, 2020)? |
cord-269023-g21a9ik2 | But might it have a function during fetal development? |
cord-269023-g21a9ik2 | Can they be re- infected- and if so, would they suffer milder disease? |
cord-269023-g21a9ik2 | Could these people be partially protected? |
cord-269023-g21a9ik2 | Do individuals with low- titer antibodies have fewer memory B cells to combat a future infection? |
cord-269023-g21a9ik2 | Does it influence the efficacy or durability of the vaccine? |
cord-269023-g21a9ik2 | Does it matter? |
cord-269023-g21a9ik2 | Edward Jenner or Benjamin Jesty? |
cord-269023-g21a9ik2 | Finally: what about the diffuse, systemic manifestations of SARS- CoV-2 infection? |
cord-269023-g21a9ik2 | First: does the cell that I am surveying belong to my body? |
cord-269023-g21a9ik2 | First: what determines the strength and durability of an immune response to the virus? |
cord-269023-g21a9ik2 | How could you detect a resident inside one of these houses, unless the resident happened to poke his head outside?'' |
cord-269023-g21a9ik2 | How does the coronavirus behave inside a patient? |
cord-269023-g21a9ik2 | How, then, was the T cell detecting NP? |
cord-269023-g21a9ik2 | I interferon activity and inflammatory responses in severe COVID-19 patients Who discovered smallpox vaccination? |
cord-269023-g21a9ik2 | In other words, is there a difference between the infected and the infectious( if so, more stringent isolation protocols might be deployed on those that are infectious until they clear the virus)? |
cord-269023-g21a9ik2 | More generally, why do infections by some viruses, or inoculation with some vaccines, precipitate durable, long- term responses, while the immunity to others wanes over time, causing re- infections, and requiring''boosters''for continuous immunity? |
cord-269023-g21a9ik2 | Novel Virus and Novel Case Do Antigens Bear Instructions for antibody specificity, or do they select cell lines that arise by mutation? |
cord-269023-g21a9ik2 | Or take an even more basic question that has enormous epidemiological and public policy significance: is there a level, or threshold, of viral load that a patient must carry in order to infect others? |
cord-269023-g21a9ik2 | Second: why do some people recover from infection, while others progress to a fulminant, deadly disease? |
cord-269023-g21a9ik2 | What if he stuck a thorn in one of the starfish's feet? |
cord-269023-g21a9ik2 | What if, Burnet reasoned, every B cell expressed only one antibody? |
cord-269023-g21a9ik2 | What words does one use- what phrases- to adequately capture the difference in living in the BV versus the AV- Before Virus and After Virus? |
cord-269023-g21a9ik2 | Where did these antibodies come from? |
cord-269023-g21a9ik2 | Why? |
cord-269023-g21a9ik2 | do they select cell lines[ that are specific for the antigen- i.e. by clonal selection]''? |